Vivani Medical, Inc. (VANI)Healthcare | Biotechnology | Alameda, United States | NasdaqCM
1.42 USD
+0.06
(4.412%)
⇧
(July 13, 2026, 4 p.m.
EDT)
After hours: 1.38 -0.04 (-0.043%) ⇩ (July 13, 2026, 6:26 p.m. EDT) |
Hot Take ↕ | July 11, 2026, 6:36 a.m. EDT
The immediate catalyst here is the strategic partnership with Novo Nordisk, which has transformed Vivani from a speculative biotech into a potential weight-loss drug contender. This corporate validation is driving aggressive speculation, pushing the stock toward the $2.00 psychological barrier where heavy option open interest sits. However, the underlying business remains precarious; the company is burning cash, has negative earnings, and carries significant debt relative to its tiny market cap. While the momentum is currently strong due to the partnership news, the lack of profitability and the volatile nature of the biotech sector mean this rally could stall if clinical trials face delays. The statistical forecast models a slight downside drift, highlighting the tension between the hype and the weak fundamentals. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.048937 |
| AutoETS | 0.124815 |
| MSTL | 0.134668 |
| AutoTheta | 0.140863 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 55% |
| H-stat | 0.73 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.194 |
| Excess Kurtosis | -1.05 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 95.756 |
| Market Cap | 122,453,840 |
| Forward P/E | -4.06 |
| Beta | 3.29 |
| Previous Name | Second Sight Medical Products, Inc. |
| Website | https://www.vivani.com |
As of July 11, 2026, 6:36 a.m. EDT: Speculators are overwhelmingly bullish on the upside, evidenced by massive open interest in $2.00 calls across all expirations compared to negligible put activity. The $2.00 strike serves as a primary resistance target where traders are positioning for a breakout, while the lack of protective puts suggests a 'long-only' sentiment betting on the Novo Nordisk partnership catalysts to drive a rapid re-rating.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.087248325 |
| Address1 | 1,350 South Loop Road |
| All Time High | 576.48 |
| All Time Low | 0.754 |
| Ask | 1.72 |
| Ask Size | 2 |
| Average Analyst Rating | 1.3 - Strong Buy |
| Average Daily Volume10 Day | 1,810,570 |
| Average Daily Volume3 Month | 501,563 |
| Average Volume | 501,563 |
| Average Volume10Days | 1,810,570 |
| Beta | 3.291 |
| Bid | 1.04 |
| Bid Size | 2 |
| Book Value | 0.225 |
| City | Alameda |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.42 |
| Current Ratio | 3.181 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 1.48 |
| Day Low | 1.34 |
| Debt To Equity | 95.756 |
| Display Name | Vivani Medical |
| Dividend Date | 1,578,268,800 |
| Earnings Timestamp | 1,778,702,400 |
| Earnings Timestamp End | 1,786,651,200 |
| Earnings Timestamp Start | 1,786,651,200 |
| Ebitda | -27,364,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -4.421 |
| Enterprise Value | 120,979,848 |
| Eps Forward | -0.35 |
| Eps Trailing Twelve Months | -0.4 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.2334 |
| Fifty Day Average Change | 0.18659997 |
| Fifty Day Average Change Percent | 0.15128909 |
| Fifty Two Week Change Percent | -8.724833 |
| Fifty Two Week High | 1.92 |
| Fifty Two Week High Change | -0.5 |
| Fifty Two Week High Change Percent | -0.2604167 |
| Fifty Two Week Low | 0.923 |
| Fifty Two Week Low Change | 0.49699998 |
| Fifty Two Week Low Change Percent | 0.5384615 |
| Fifty Two Week Range | 0.923 - 1.92 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,416,407,400,000 |
| Float Shares | 35,685,811 |
| Forward Eps | -0.35 |
| Forward P E | -4.0571427 |
| Free Cashflow | -16,415,000 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 42 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.5794 |
| Held Percent Institutions | 0.06503 |
| Implied Shares Outstanding | 86,235,104 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,660,867,200 |
| Last Split Factor | 1:3 |
| Long Business Summary | Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases. Its pipeline includes NPM-139 for chronic weight management in patients who are obese or overweight; NPM-133 a semaglutide implant for the treatment of patients with type 2 diabetes; NPM-115, an exenatide implant candidate for chronic weight management in patients who are obese or overweight; and OKV-119, an exenatide implant for the treatment of obesity and diabetes in companion animals, including cats and dogs. The company is headquartered in Alameda, California. |
| Long Name | Vivani Medical, Inc. |
| Market | us_market |
| Market Cap | 122,453,840 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_260862802 |
| Most Recent Quarter | 1,774,915,200 |
| Name Change Date | 2,026-07-13 |
| Net Income To Common | -27,087,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 117,710,916 |
| Number Of Analyst Opinions | 3 |
| Open | 1.39 |
| Operating Cashflow | -25,353,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 415 506 8462 |
| Post Market Change | -0.0431 |
| Post Market Change Percent | -3.0352113 |
| Post Market Price | 1.3769 |
| Post Market Time | 1,783,981,601 |
| Prev Name | Second Sight Medical Products, Inc. |
| Previous Close | 1.36 |
| Price Hint | 4 |
| Price To Book | 6.311111 |
| Profit Margins | 0.0 |
| Quick Ratio | 3.018 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.33333 |
| Region | US |
| Regular Market Change | 0.0599999 |
| Regular Market Change Percent | 4.41176 |
| Regular Market Day High | 1.48 |
| Regular Market Day Low | 1.34 |
| Regular Market Day Range | 1.34 - 1.48 |
| Regular Market Open | 1.39 |
| Regular Market Previous Close | 1.36 |
| Regular Market Price | 1.42 |
| Regular Market Time | 1,783,972,800 |
| Regular Market Volume | 626,375 |
| Return On Assets | -0.44689 |
| Return On Equity | -1.76411 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 86,235,104 |
| Shares Percent Shares Out | 0.005 |
| Shares Short | 432,659 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 335,967 |
| Short Name | Vivani Medical, Inc. |
| Short Percent Of Float | 0.01 |
| Short Ratio | 2.61 |
| Source Interval | 15 |
| State | CA |
| Symbol | VANI |
| Target High Price | 4.0 |
| Target Low Price | 3.5 |
| Target Mean Price | 3.83333 |
| Target Median Price | 4.0 |
| Total Cash | 19,749,000 |
| Total Cash Per Share | 0.229 |
| Total Debt | 18,275,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.4 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.310015 |
| Two Hundred Day Average Change | 0.109984994 |
| Two Hundred Day Average Change Percent | 0.08395705 |
| Type Disp | Equity |
| Volume | 626,375 |
| Website | https://www.vivani.com |
| Zip | 94,502 |